Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? Results from a randomized clinical trial

Genetics in Medicine

Volumn 18, Issue 2, 2016, Pages 137-144

  Wevers, Marijke R ^a,b   Ausems, Margreet G E M ^b   Verhoef, Senno ^a   Bleiker, Eveline M A ^a   Hahn, Daniela E E ^a   Brouwer, Titia ^b   Hogervorst, Frans B L ^a   Van Der Luijt, Rob B ^b   Van Dalen, Thijs ^c   Theunissen, Evert B ^d   Van Ooijen, Bart ^e   De Roos, Marnix A ^f   Borgstein, Paul J ^g   Vrouenraets, Bart C ^g   Vriens, Eline ^h   Bouma, Wim H ⁱ   Rijna, Herman ^j   Vente, Johannes P ^k   Kieffer, Jacobien M ^a   Valdimarsdottir, Heiddis B ^l   Rutgers, Emiel J T ^a   Witkamp, Arjen J ^b   Aaronson, Neil K ^a   more..

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c DEPARTMENT OF SURGERY   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

^e MEANDER MEDICAL CENTER   (Netherlands)

^f Ziekenhuis Rivierenland   (Netherlands)

^g ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^h Tergooi Hospitals   (Netherlands)

ⁱ GELRE HOSPITALS   (Netherlands)

^j Infection and Immunology   (Netherlands)

^k Zuwe Hofpoort Ziekenhuis   (Netherlands)

^l REYKJAVIK UNIVERSITY   (Iceland)

more..

Author keywords

BRCA1 2; breast cancer; genetic counseling and testing; psychosocial distress; quality of life

Indexed keywords

ADULT; ARTICLE; BODY IMAGE; BREAST CANCER; CANCER DIAGNOSIS; CONTROLLED STUDY; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MENTAL STRESS; PATIENT SATISFACTION; PATIENT WORRY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEXUALITY; SOCIAL STRESS; AGED; BREAST NEOPLASMS; MIDDLE AGED; PSYCHOLOGY; TIME FACTOR; TUMOR SUPPRESSOR GENE; YOUNG ADULT;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC TESTING; HUMANS; MIDDLE AGED; TIME FACTORS; YOUNG ADULT;

EID: 84957684443     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2015.50     Document Type: Article

References (39)

1. Rhiem K, Engel C, Graeser M., et al. The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study. Breast Cancer Res 2012; 14: R156
2. Kiely BE, Jenkins MA, McKinley JM., et al. Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab). Breast Cancer Res Treat 2010; 120: 715-723
3. Metcalfe KA, Lubinski J, Ghadirian P., et al.; Hereditary Breast Cancer Clinical Study Group. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. J Clin Oncol 2008; 26: 1093-1097
4. Tercyak KP, Peshkin BN, Brogan BM., et al. Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing. J Clin Oncol 2007; 25: 285-291
5. Lostumbo L, Carbine NE, Wallace J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev 2010; 11: CD002748
6. Metcalfe K, Gershman S, Ghadirian P., et al. Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis. BMJ 2014; 348: g226
7. Bresser PJ, Seynaeve C, Van Gool AR., et al. Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women. Plast Reconstr Surg 2006; 117: 1675-1682; discussion 1683
8. Frost MH, Slezak JM, Tran NV., et al. Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol 2005; 23: 7849-7856
9. Geiger AM, West CN, Nekhlyudov L., et al. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy. J Clin Oncol 2006; 24: 1350-1356
10. Wevers MR, Hahn DE, Verhoef S., et al. Breast cancer genetic counseling after diagnosis but before treatment: a pilot study on treatment consequences and psychological impact. Patient Educ Couns 2012; 89: 89-95
11. Ardern-Jones A, Kenen R, Eeles R. Too much, too soon?. Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40. Eur J Cancer Care (Engl) 2005; 14: 272-281
12. Wevers MR, Aaronson NK, Verhoef S., et al. Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial. Br J Cancer 2014; 110: 1081-1087
13. Wevers MR, Ausems MG, Verhoef S., et al. Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: design of a multicenter randomized clinical trial. BMC Cancer 2011; 11: 6
14. The Netherlands Foundation for the Detection of Hereditary Tumours (STOET), the Dutch Society of Clinical Genetics (VKGN). Erfelijke tumoren: richtijnen voor diagnostiek en preventie. 2005.pp 10-13
15. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Academic Press: New York, 1977
16. Schou I, Ekeberg ?, Ruland CM, Sandvik L, K?esen R. Pessimism as a predictor of emotional morbidity one year following breast cancer surgery. Psychooncology 2004; 13: 309-320
17. Hegel MT, Moore CP, Collins ED., et al. Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer 2006; 107: 2924-2931
18. Schou I, Ekeberg ?, Sandvik L, Hjermstad MJ, Ruland CM. Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-up study compared with the general population. Qual Life Res 2005; 14: 1813-1823
19. Schlich-Bakker KJ, Ausems MG, Schipper M, Ten Kroode HF, W?l?-Rodenhuis CC, Van den Bout J. BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy. Breast Cancer Res Treat 2008; 109: 507-514
20. Van Riel E, W?l?-Rodenhuis CC, Verhoef S, Rutgers EJ, Ausems MG. BRCA testing of breast cancer patients: medical specialists' referral patterns, knowledge and attitudes to genetic testing. Eur J Cancer Care (Engl) 2010; 19: 369-376
21. National Collaborating Centre for Cancer. National Institute for Health and Care Excellence (NICE) Guideline Familial Breast Cancer 2013: Classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer, 2013, https://beta.nice.org.uk/resource/CG164/pdf/c/cg164-familial-breast-cancer-clinicalevidence-review?id=6kirgc7xvo7mh43kv7uchja5um. Accessed 5 May 2014
22. Breast Cancer Guideline 2.0, 2013. http://www.oncoline.nl/mammacarcinoom. Accessed 7 February 2013
23. Zilliacus E, Meiser B, Gleeson M., et al. Are we being overly cautious?. A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer. Support Care Cancer 2012; 20: 2949-2958
24. Christie J, Quinn GP, Malo T., et al. Cognitive and psychological impact of BRCA genetic counseling in before and after definitive surgery breast cancer patients. Ann Surg Oncol 2012; 19: 4003-4011
25. Hilgart JS, Coles B, Iredale R. Cancer genetic risk assessment for individuals at risk of familial breast cancer. Cochrane Database Syst Rev 2012; 2: CD003721
26. Nordin K, Roshanai A, Bjorvatn C., et al. Is genetic counseling a stressful event?. Acta Oncol 2011; 50: 1089-1097
27. Douma KF, Aaronson NK, Vasen HF., et al. Psychological distress and use of psychosocial support in familial adenomatous polyposis. Psychooncology 2010; 19: 289-298
28. Watson M, Duvivier V, Wade Walsh M., et al. Family history of breast cancer: what do women understand and recall about their genetic risk?. J Med Genet 1998; 35: 731-738
29. Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994; 12: 843-850
30. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979; 41: 209-218
31. Brom D, Kleber RJ. De Schok Verwerkingslijst [The Impact of Event Scale]. Ned Tijdschr Psych 1985; 41: 164-168
32. Aaronson NK, Ahmedzai S, Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376
33. Sprangers MA, Groenvold M, Arraras JI., et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 1996; 14: 2756-2768
34. Holmes-Rovner M, Kroll J, Schmitt N., et al. Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Decis Making 1996; 16: 58-64
35. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370
36. de Bock GH, Bonnema J, Zwaan RE, Van de Velde CJ, Kievit J, Stiggelbout AM. Patient's needs and preferences in routine follow-up after treatment for breast cancer. Br J Cancer 2004; 90: 1144-1150
37. Turner J, Kelly B, Swanson C, Allison R, Wetzig N. Psychosocial impact of newly diagnosed advanced breast cancer. Psychooncology 2005; 14: 396-407
38. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997; 27: 363-370
39. Pieterse AH, Ausems MG, Van Dulmen AM, Beemer FA, Bensing JM. Initial cancer genetic counseling consultation: change in counselees' cognitions and anxiety, and association with addressing their needs and preferences. Am J Med Genet A 2005; 137: 27-35